Organigram Global Inc. (TSX: OGI)
OGI trades on the Toronto Stock Exchange in Life Sciences, headquartered in New Brunswick. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Close · October 14, 2026
C$1.28
-3.03% on the day
Market cap (C$)
C$200.3M
TMX list, September 30, 2026
Market cap (US$)
US$140.4M
Micro cap at 1.4263 C$/US$
1-year return
-51.9%
-44.6% year to date
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for OGI.TO, last bar 2026-10-14, computed by Sophia Capital.
Profile
| Field | Value |
|---|---|
| Ticker | OGI on the Toronto Stock Exchange |
| Yahoo symbol | OGI.TO |
| Sector | Life Sciences, Cannabis |
| Headquarters | New Brunswick |
| Listed | 2019-08-22 |
| Listing type | TSXV Grad |
| Shares outstanding | 141,037,409 |
| Also listed on | NasdaqGS |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001620737 |
| Website | No company website on record |
| US listing | OGI |
Returns
| Window | Return |
|---|---|
| 1 day | -3.0% |
| 1 week | -8.6% |
| 1 month | -14.1% |
| 3 months | +2.4% |
| 6 months | -35.4% |
| Year to date | -44.6% |
| 1 year | -51.9% |
| From 52-week high | -55.9% |
| 52-week range | C$1.23 to C$2.90 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
130 documents in 12 types. Each title links to the document at its source.
Annual financial statements (2)
| Document | Type | Filed |
|---|---|---|
| Audited consolidated financial statements of the Company and notes thereto as of September 30, 2025 and 2024, and for the year ended September 30,… Period 2025-09-30 | Annual financial statements (40-F) | 2025-12-16 |
| Audited consolidated financial statements of the Company and notes thereto as of September 30, 2024 and 2023, and for the twelve months ended… Period 2024-09-30 | Annual financial statements (40-F) | 2024-12-18 |
Interim financial statements (6)
| Document | Type | Filed |
|---|---|---|
| Condensed Consolidated Interim Unaudited Financial Statements for the three and nine months ended June 30, 2026 Period 2026-06-30 | Interim financial statements (6-K) | 2026-08-11 |
| Condensed Consolidated Interim Unaudited Financial Statements for the three and six months ended March 31, 2026 Period 2026-03-31 | Interim financial statements (6-K) | 2026-05-12 |
| Condensed Consolidated Interim Unaudited Financial Statements for the three months ended December 31, 2025 Period 2025-12-31 | Interim financial statements (6-K) | 2026-02-10 |
| Condensed Consolidated Interim Unaudited Financial Statements for the three and nine months ended June 30, 2025 Period 2025-06-30 | Interim financial statements (6-K) | 2025-08-13 |
MD&A (8)
| Document | Type | Filed |
|---|---|---|
| Management's Discussion and Analysis for the year ended September 30, 2025 Period 2025-09-30 | MD&A (annual) (40-F) | 2025-12-16 |
| Management's Discussion and Analysis for the twelve months ended September 30, 2024 Period 2024-09-30 | MD&A (annual) (40-F) | 2024-12-18 |
| Management's Discussion and Analysis for the three and nine months ended June 30, 2026 Period 2026-06-30 | MD&A (interim) (6-K) | 2026-08-11 |
| Management's Discussion and Analysis for the three and six months ended March 31, 2026 Period 2026-03-31 | MD&A (interim) (6-K) | 2026-05-12 |
Annual information form (2)
| Document | Type | Filed |
|---|---|---|
| Annual Information Form of the Company for the year ended September 30, 2025 Period 2025-09-30 | Annual information form (40-F) | 2025-12-16 |
| Annual Information Form of the Company for the twelve months ended September 30, 2024 Period 2024-09-30 | Annual information form (40-F) | 2024-12-18 |
Material change report (5)
| Document | Type | Filed |
|---|---|---|
| Material Change Report dated August 31, 2026 | Material change report (6-K) | 2026-09-01 |
| Material Change Report dated March 2, 2026 | Material change report (6-K) | 2026-03-03 |
| Material Change Report dated December 4, 2025 | Material change report (6-K) | 2025-12-04 |
| Material Change Report dated June 4, 2025 | Material change report (6-K) | 2025-06-04 |
News release (48)
| Document | Type | Filed |
|---|---|---|
| News Release dated September 30, 2026 | News release (6-K) | 2026-09-30 |
| News Release dated September 2, 2026 | News release (6-K) | 2026-09-03 |
| News Release dated August 20, 2026 | News release (6-K) | 2026-08-20 |
| News Release announcing results for the three and nine months ended June 30, 2026 dated August 11, 2026 Period 2026-06-30 | News release (6-K) | 2026-08-11 |
Management information circular / proxy (4)
| Document | Type | Filed |
|---|---|---|
| Notice of Annual General and Special Meeting of Shareholders and Management Information Circular dated February 12, 2025 | Management information circular (6-K) | 2025-03-03 |
| Notice | Notice of meeting (6-K) | 2026-03-09 |
| Notice of Record and Meeting Date dated January 27, 2026 | Notice of meeting (6-K) | 2026-01-28 |
| Form of Proxy | Form of proxy / voting instruction (6-K) | 2025-03-03 |
Report of voting results (2)
| Document | Type | Filed |
|---|---|---|
| Report on Voting Results dated March 30, 2026 | Report of voting results (6-K) | 2026-03-31 |
| Report on Voting Results dated March 24, 2025 | Report of voting results (6-K) | 2025-03-25 |
Annual report (5)
| Document | Type | Filed |
|---|---|---|
| 40-F Period 2025-09-30 | Annual report (40-F) (40-F) | 2025-12-16 |
| FORM 40-F/A Period 2024-09-30 | Annual report (40-F) (40-F/A) | 2024-12-20 |
| 40-F Period 2024-09-30 | Annual report (40-F) (40-F) | 2024-12-18 |
| Glossy Annual Report Period 2025-09-30 | Annual report to shareholders (40-F) | 2025-12-16 |
Early warning / ownership (4)
| Document | Type | Filed |
|---|---|---|
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2026-04-17 |
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2026-02-20 |
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2025-03-03 |
| Schedule 13D amendment | Schedule 13D (SC 13D/A) | 2024-12-10 |
Certification (21)
| Document | Type | Filed |
|---|---|---|
| Form 52-109F2 - Certification of Interim Filings of Chief Executive Officer dated August 11, 2026 | Certification (52-109F2) (6-K) | 2026-08-11 |
| Form 52-109F2 - Certification of Interim Filings of Chief Financial Officer dated August 11, 2026 | Certification (52-109F2) (6-K) | 2026-08-11 |
| Form 52-109F2 - Certification of Interim Filings of Chief Executive Officer dated May 12, 2026 | Certification (52-109F2) (6-K) | 2026-05-12 |
| Form 52-109F2 - Certification of Interim Filings of Chief Financial Officer dated May 12, 2026 | Certification (52-109F2) (6-K) | 2026-05-12 |
Other (23)
| Document | Type | Filed |
|---|---|---|
| To register for the conference call, please use this link: Period 2025-03-31 | Conference call transcript (6-K) | 2025-05-05 |
| Consent of PKF O’Connor Davies LLP, Independent Registered Public Accounting Firm Period 2025-09-30 | Consent (40-F) | 2025-12-16 |
| Consent of PKF O’Connor Davies LLP, Independent Registered Public Accounting Firm Period 2024-09-30 | Consent (40-F) | 2024-12-18 |
| Consent of KPMG, LLP, Independent Registered Public Accounting Firm Period 2024-09-30 | Consent (40-F) | 2024-12-18 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2021-03-25 | Equity | US$175.0M | US$175.0M | SEC EDGAR |
| 2019-07-03 | Equity | US$24K | US$24K | SEC EDGAR |
| 2016-09-01 | Equity | US$50K | US$50K | SEC EDGAR |
| 2016-07-21 | Equity, Option To Acquire, Security To Be Acquired | US$77K | US$128K | SEC EDGAR |
| 2015-12-08 | Equity, Debt, Option To Acquire, Security To Be Acquired, Other | US$150K | US$200K | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| CRRX | CareRx Corporation | TSX | C$203.0M | -0.9% | -9.5% |
| RX | BioSyent Inc. | TSXV | C$191.8M | +0.3% | +37.6% |
| CHLT | Custom Health Holdings Inc. | TSX | C$209.2M | -10.5% | Under a year of closes |
| LOVE | Cannara Biotech Inc. | TSX | C$212.2M | +4.0% | +20.2% |
| NURS | Hydreight Technologies Inc. | TSXV | C$178.7M | +11.1% | -18.0% |
The app has the price chart, every filing, private raises and the full peer set for OGI.
Open in the app